Auto-immunity and inflammation driven by low NAD+, niacinamide is therapeutic
-
Not really surprising findings, considering the extensive published evidence showing NAD+ is crucial for immune system function, and that depletion of NAD+ can cause both immunodeficiency, as well as inflammatory “auto-immune” conditions, the latter of which are thought to involved overactive immune system function targeting a specific organ or tissue.
http://dx.doi.org/10.1016/j.cell.2024.05.034
https://www.sciencedaily.com/releases/2024/06/240614155341.htm
“…Nucleotide-binding oligomerization domain-like receptors (NLRs) are a large family of important molecules involved in inflammatory signaling. They are generally thought to function as innate immune sensors that detect threats. However, the specific roles of several NLRs in sensing are not yet understood. Scientists at St. Jude conducted a large screen, testing a specific NLR, NLRC5, to see what threats activate it. Through their efforts, they discovered that depletion of nicotinamide adenine dinucleotide (NAD), a molecule essential in energy production, triggers NLRC5-mediated cell death through PANoptosis.”
“…Upon identifying the heme-containing PAMP, DAMP and cytokine combinations that trigger NLRC5-dependent inflammatory cell death, the researchers further investigated how NLRC5 is regulated. They found that NAD levels drive NLRC5 protein expression. If NAD is depleted, that sounds an alarm that there is a threat the immune system should recognize. The researchers found that depletion of NAD is sensed by NLRC5, triggering PANoptosis. “By supplementing with the NAD precursor, nicotinamide, we reduced NLRC5 protein expression and PANoptosis,” said co-first author Nagakannan Pandian, PhD, St. Jude Department of Immunology. “Therapeutically, nicotinamide has been widely studied as a nutrient supplement, and our findings suggest it could be helpful in treating inflammatory diseases.”